http://www.streetinsider.com Latest StreetInsider.com News Articles en-us Copyright 2026, StreetInsider.com rss@streetinsider.com (SI RSS) rss@streetinsider.com (SI RSS) Tue, 09 Jun 2026 16:06:00 -0400 http://blogs.law.harvard.edu/tech/rss http://www.streetinsider.com/images/rss_logo.gif http://www.streetinsider.com 143 28 0 1 2 3 21 22 23 Saturday Sunday http://www.streetinsider.com/SEC+Filings/Form++S-8++++++++Lipocine+Inc.++++++++++++++++++++++++/26623645.html si-local-file:///var/storage/secattach/20260609/26623645.html http://www.streetinsider.com/SEC+Filings/Form++S-8++++++++Lipocine+Inc.++++++++++++++++++++++++/26623645.html Tue, 09 Jun 2026 16:06:00 -0400 LPCN O.13604276 http://www.streetinsider.com/SEC+Filings/Form++S-8++++++++Lipocine+Inc.++++++++++++++++++++++++/26623645.html si-local-file:///var/storage/secattach/20260609/26623645.html http://www.streetinsider.com/SEC+Filings/Form++S-8++++++++Lipocine+Inc.++++++++++++++++++++++++/26623645.html Tue, 09 Jun 2026 16:06:00 -0400 LPCN O.13604276 http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Lipocine+Inc.+++++++++++++For%3A+Jun+03++Filed+by%3A+Ono+Richard+Dana/26605589.html si-local-file:///var/storage/secattach/20260604/26605589.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Lipocine+Inc.+++++++++++++For%3A+Jun+03++Filed+by%3A+Ono+Richard+Dana/26605589.html Thu, 04 Jun 2026 16:06:00 -0400 LPCN O.13604276 http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Lipocine+Inc.+++++++++++++For%3A+Jun+03++Filed+by%3A+Ono+Richard+Dana/26605589.html si-local-file:///var/storage/secattach/20260604/26605589.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Lipocine+Inc.+++++++++++++For%3A+Jun+03++Filed+by%3A+Ono+Richard+Dana/26605589.html Thu, 04 Jun 2026 16:06:00 -0400 LPCN O.13604276 http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Lipocine+Inc.+++++++++++++For%3A+Jun+03++Filed+by%3A+Jene+Jill+M./26605591.html si-local-file:///var/storage/secattach/20260604/26605591.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Lipocine+Inc.+++++++++++++For%3A+Jun+03++Filed+by%3A+Jene+Jill+M./26605591.html Thu, 04 Jun 2026 16:06:00 -0400 LPCN O.13604276 http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Lipocine+Inc.+++++++++++++For%3A+Jun+03++Filed+by%3A+Jene+Jill+M./26605591.html si-local-file:///var/storage/secattach/20260604/26605591.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Lipocine+Inc.+++++++++++++For%3A+Jun+03++Filed+by%3A+Jene+Jill+M./26605591.html Thu, 04 Jun 2026 16:06:00 -0400 LPCN O.13604276 http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Lipocine+Inc.+++++++++++++For%3A+Jun+03++Filed+by%3A+Higuchi+John+W./26605594.html si-local-file:///var/storage/secattach/20260604/26605594.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Lipocine+Inc.+++++++++++++For%3A+Jun+03++Filed+by%3A+Higuchi+John+W./26605594.html Thu, 04 Jun 2026 16:06:00 -0400 LPCN O.13604276 http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Lipocine+Inc.+++++++++++++For%3A+Jun+03++Filed+by%3A+Higuchi+John+W./26605594.html si-local-file:///var/storage/secattach/20260604/26605594.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Lipocine+Inc.+++++++++++++For%3A+Jun+03++Filed+by%3A+Higuchi+John+W./26605594.html Thu, 04 Jun 2026 16:06:00 -0400 LPCN O.13604276 http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++Lipocine+Inc.+++++++++++++For%3A+Jun+03/26605613.html si-local-file:///var/storage/secattach/20260604/26605613.html http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++Lipocine+Inc.+++++++++++++For%3A+Jun+03/26605613.html Thu, 04 Jun 2026 16:06:00 -0400 LPCN O.13604276 http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++Lipocine+Inc.+++++++++++++For%3A+Jun+03/26605613.html si-local-file:///var/storage/secattach/20260604/26605613.html http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++Lipocine+Inc.+++++++++++++For%3A+Jun+03/26605613.html Thu, 04 Jun 2026 16:06:00 -0400 LPCN O.13604276 http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++Lipocine+Inc.+++++++++++++For%3A+Jun+04/26603348.html si-local-file:///var/storage/secattach/20260604/26603348.html http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++Lipocine+Inc.+++++++++++++For%3A+Jun+04/26603348.html Thu, 04 Jun 2026 09:00:00 -0400 LPCN O.13604276 http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++Lipocine+Inc.+++++++++++++For%3A+Jun+04/26603348.html si-local-file:///var/storage/secattach/20260604/26603348.html http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++Lipocine+Inc.+++++++++++++For%3A+Jun+04/26603348.html Thu, 04 Jun 2026 09:00:00 -0400 LPCN O.13604276 http://www.streetinsider.com/Press+Releases/Lipocine+Inc.+to+Host+Virtual+KOL+Event+Highlighting+Unmet+Needs+in+Postpartum+Depression+and+the+Clinical+Profile+of+LPCN+1154/26602692.html <div class="xn-content"> <p class="prntac">Live webinar to take place on <chron>Friday, June 12, 2026</chron> at <chron>11:00 AM Eastern Time</chron></p><p><span class="legendSpanClass"><location value="LU/us.ut.sltlkc" idsrc="xmltag.org" >SALT LAKE CITY</location></span>, <span class="legendSpanClass"><chron>June 4, 2026</chron></span> /PRNewswire/ -- Lipocine Inc. (Nasdaq: LPCN), a specialty pharmaceutical company focused on the development of novel oral therapeutics, today announced that it will host a virtual Key Opinion Leader (KOL) event on <b><chron>Friday, June 12, 2026</chron> at <chron>11:00 AM Eastern Time</chron></b>. The event will bring together leading physicians with deep expertise in postpartum depression (PPD) to discuss the continued clinical unmet needs in PPD and the emerging clinical profile of LPCN 1154 (BRLIZIO™), <span http://www.streetinsider.com/Press+Releases/Lipocine+Inc.+to+Host+Virtual+KOL+Event+Highlighting+Unmet+Needs+in+Postpartum+Depression+and+the+Clinical+Profile+of+LPCN+1154/26602692.html Thu, 04 Jun 2026 08:00:00 -0400 A.06188431 A.10277118 A.16003235 A.19655944 A.23500096 A.30746152 A.32845002 LPCN O.00052323 O.00173928 O.00805111 O.02863032 O.03307993 O.13604276 O.50936666 O.50982008 http://www.streetinsider.com/Press+Releases/Lipocine+Inc.+to+Host+Virtual+KOL+Event+Highlighting+Unmet+Needs+in+Postpartum+Depression+and+the+Clinical+Profile+of+LPCN+1154/26602692.html <div class="xn-content"> <p class="prntac">Live webinar to take place on <chron>Friday, June 12, 2026</chron> at <chron>11:00 AM Eastern Time</chron></p><p><span class="legendSpanClass"><location value="LU/us.ut.sltlkc" idsrc="xmltag.org" >SALT LAKE CITY</location></span>, <span class="legendSpanClass"><chron>June 4, 2026</chron></span> /PRNewswire/ -- Lipocine Inc. (Nasdaq: LPCN), a specialty pharmaceutical company focused on the development of novel oral therapeutics, today announced that it will host a virtual Key Opinion Leader (KOL) event on <b><chron>Friday, June 12, 2026</chron> at <chron>11:00 AM Eastern Time</chron></b>. The event will bring together leading physicians with deep expertise in postpartum depression (PPD) to discuss the continued clinical unmet needs in PPD and the emerging clinical profile of LPCN 1154 (BRLIZIO™), <span http://www.streetinsider.com/Press+Releases/Lipocine+Inc.+to+Host+Virtual+KOL+Event+Highlighting+Unmet+Needs+in+Postpartum+Depression+and+the+Clinical+Profile+of+LPCN+1154/26602692.html Thu, 04 Jun 2026 08:00:00 -0400 A.06188431 A.10277118 A.16003235 A.19655944 A.23500096 A.30746152 A.32845002 LPCN O.00052323 O.00173928 O.00805111 O.02863032 O.03307993 O.13604276 O.50936666 O.50982008 http://www.streetinsider.com/Press+Releases/Lipocine+Inc.+to+Host+Virtual+KOL+Event+Highlighting+Unmet+Needs+in+Postpartum+Depression+and+the+Clinical+Profile+of+LPCN+1154/26602692.html <div class="xn-content"> <p class="prntac">Live webinar to take place on <chron>Friday, June 12, 2026</chron> at <chron>11:00 AM Eastern Time</chron></p><p><span class="legendSpanClass"><location value="LU/us.ut.sltlkc" idsrc="xmltag.org" >SALT LAKE CITY</location></span>, <span class="legendSpanClass"><chron>June 4, 2026</chron></span> /PRNewswire/ -- Lipocine Inc. (Nasdaq: LPCN), a specialty pharmaceutical company focused on the development of novel oral therapeutics, today announced that it will host a virtual Key Opinion Leader (KOL) event on <b><chron>Friday, June 12, 2026</chron> at <chron>11:00 AM Eastern Time</chron></b>. The event will bring together leading physicians with deep expertise in postpartum depression (PPD) to discuss the continued clinical unmet needs in PPD and the emerging clinical profile of LPCN 1154 (BRLIZIO™), <span http://www.streetinsider.com/Press+Releases/Lipocine+Inc.+to+Host+Virtual+KOL+Event+Highlighting+Unmet+Needs+in+Postpartum+Depression+and+the+Clinical+Profile+of+LPCN+1154/26602692.html Thu, 04 Jun 2026 08:00:00 -0400 A.06188431 A.10277118 A.16003235 A.19655944 A.23500096 A.30746152 A.32845002 LPCN O.00052323 O.00173928 O.00805111 O.02863032 O.03307993 O.13604276 O.50936666 O.50982008 http://www.streetinsider.com/Press+Releases/Lipocine+Inc.+to+Host+Virtual+KOL+Event+Highlighting+Unmet+Needs+in+Postpartum+Depression+and+the+Clinical+Profile+of+LPCN+1154/26602692.html <div class="xn-content"> <p class="prntac">Live webinar to take place on <chron>Friday, June 12, 2026</chron> at <chron>11:00 AM Eastern Time</chron></p><p><span class="legendSpanClass"><location value="LU/us.ut.sltlkc" idsrc="xmltag.org" >SALT LAKE CITY</location></span>, <span class="legendSpanClass"><chron>June 4, 2026</chron></span> /PRNewswire/ -- Lipocine Inc. (Nasdaq: LPCN), a specialty pharmaceutical company focused on the development of novel oral therapeutics, today announced that it will host a virtual Key Opinion Leader (KOL) event on <b><chron>Friday, June 12, 2026</chron> at <chron>11:00 AM Eastern Time</chron></b>. The event will bring together leading physicians with deep expertise in postpartum depression (PPD) to discuss the continued clinical unmet needs in PPD and the emerging clinical profile of LPCN 1154 (BRLIZIO™), <span http://www.streetinsider.com/Press+Releases/Lipocine+Inc.+to+Host+Virtual+KOL+Event+Highlighting+Unmet+Needs+in+Postpartum+Depression+and+the+Clinical+Profile+of+LPCN+1154/26602692.html Thu, 04 Jun 2026 08:00:00 -0400 A.06188431 A.10277118 A.16003235 A.19655944 A.23500096 A.30746152 A.32845002 LPCN O.00052323 O.00173928 O.00805111 O.02863032 O.03307993 O.13604276 O.50936666 O.50982008 http://www.streetinsider.com/Press+Releases/Lipocine+Inc.+to+Host+Virtual+KOL+Event+Highlighting+Unmet+Needs+in+Postpartum+Depression+and+the+Clinical+Profile+of+LPCN+1154/26602692.html <div class="xn-content"> <p class="prntac">Live webinar to take place on <chron>Friday, June 12, 2026</chron> at <chron>11:00 AM Eastern Time</chron></p><p><span class="legendSpanClass"><location value="LU/us.ut.sltlkc" idsrc="xmltag.org" >SALT LAKE CITY</location></span>, <span class="legendSpanClass"><chron>June 4, 2026</chron></span> /PRNewswire/ -- Lipocine Inc. (Nasdaq: LPCN), a specialty pharmaceutical company focused on the development of novel oral therapeutics, today announced that it will host a virtual Key Opinion Leader (KOL) event on <b><chron>Friday, June 12, 2026</chron> at <chron>11:00 AM Eastern Time</chron></b>. The event will bring together leading physicians with deep expertise in postpartum depression (PPD) to discuss the continued clinical unmet needs in PPD and the emerging clinical profile of LPCN 1154 (BRLIZIO™), <span http://www.streetinsider.com/Press+Releases/Lipocine+Inc.+to+Host+Virtual+KOL+Event+Highlighting+Unmet+Needs+in+Postpartum+Depression+and+the+Clinical+Profile+of+LPCN+1154/26602692.html Thu, 04 Jun 2026 08:00:00 -0400 A.06188431 A.10277118 A.16003235 A.19655944 A.23500096 A.30746152 A.32845002 LPCN O.00052323 O.00173928 O.00805111 O.02863032 O.03307993 O.13604276 O.50936666 O.50982008 http://www.streetinsider.com/Press+Releases/Lipocine+Inc.+to+Host+Virtual+KOL+Event+Highlighting+Unmet+Needs+in+Postpartum+Depression+and+the+Clinical+Profile+of+LPCN+1154/26602692.html <div class="xn-content"> <p class="prntac">Live webinar to take place on <chron>Friday, June 12, 2026</chron> at <chron>11:00 AM Eastern Time</chron></p><p><span class="legendSpanClass"><location value="LU/us.ut.sltlkc" idsrc="xmltag.org" >SALT LAKE CITY</location></span>, <span class="legendSpanClass"><chron>June 4, 2026</chron></span> /PRNewswire/ -- Lipocine Inc. (Nasdaq: LPCN), a specialty pharmaceutical company focused on the development of novel oral therapeutics, today announced that it will host a virtual Key Opinion Leader (KOL) event on <b><chron>Friday, June 12, 2026</chron> at <chron>11:00 AM Eastern Time</chron></b>. The event will bring together leading physicians with deep expertise in postpartum depression (PPD) to discuss the continued clinical unmet needs in PPD and the emerging clinical profile of LPCN 1154 (BRLIZIO™), <span http://www.streetinsider.com/Press+Releases/Lipocine+Inc.+to+Host+Virtual+KOL+Event+Highlighting+Unmet+Needs+in+Postpartum+Depression+and+the+Clinical+Profile+of+LPCN+1154/26602692.html Thu, 04 Jun 2026 08:00:00 -0400 A.06188431 A.10277118 A.16003235 A.19655944 A.23500096 A.30746152 A.32845002 LPCN O.00052323 O.00173928 O.00805111 O.02863032 O.03307993 O.13604276 O.50936666 O.50982008 http://www.streetinsider.com/Press+Releases/Lipocine+Inc.+to+Host+Virtual+KOL+Event+Highlighting+Unmet+Needs+in+Postpartum+Depression+and+the+Clinical+Profile+of+LPCN+1154/26602692.html <div class="xn-content"> <p class="prntac">Live webinar to take place on <chron>Friday, June 12, 2026</chron> at <chron>11:00 AM Eastern Time</chron></p><p><span class="legendSpanClass"><location value="LU/us.ut.sltlkc" idsrc="xmltag.org" >SALT LAKE CITY</location></span>, <span class="legendSpanClass"><chron>June 4, 2026</chron></span> /PRNewswire/ -- Lipocine Inc. (Nasdaq: LPCN), a specialty pharmaceutical company focused on the development of novel oral therapeutics, today announced that it will host a virtual Key Opinion Leader (KOL) event on <b><chron>Friday, June 12, 2026</chron> at <chron>11:00 AM Eastern Time</chron></b>. The event will bring together leading physicians with deep expertise in postpartum depression (PPD) to discuss the continued clinical unmet needs in PPD and the emerging clinical profile of LPCN 1154 (BRLIZIO™), <span http://www.streetinsider.com/Press+Releases/Lipocine+Inc.+to+Host+Virtual+KOL+Event+Highlighting+Unmet+Needs+in+Postpartum+Depression+and+the+Clinical+Profile+of+LPCN+1154/26602692.html Thu, 04 Jun 2026 08:00:00 -0400 A.06188431 A.10277118 A.16003235 A.19655944 A.23500096 A.30746152 A.32845002 LPCN O.00052323 O.00173928 O.00805111 O.02863032 O.03307993 O.13604276 O.50936666 O.50982008 http://www.streetinsider.com/Press+Releases/Lipocine+Inc.+to+Host+Virtual+KOL+Event+Highlighting+Unmet+Needs+in+Postpartum+Depression+and+the+Clinical+Profile+of+LPCN+1154/26602692.html <div class="xn-content"> <p class="prntac">Live webinar to take place on <chron>Friday, June 12, 2026</chron> at <chron>11:00 AM Eastern Time</chron></p><p><span class="legendSpanClass"><location value="LU/us.ut.sltlkc" idsrc="xmltag.org" >SALT LAKE CITY</location></span>, <span class="legendSpanClass"><chron>June 4, 2026</chron></span> /PRNewswire/ -- Lipocine Inc. (Nasdaq: LPCN), a specialty pharmaceutical company focused on the development of novel oral therapeutics, today announced that it will host a virtual Key Opinion Leader (KOL) event on <b><chron>Friday, June 12, 2026</chron> at <chron>11:00 AM Eastern Time</chron></b>. The event will bring together leading physicians with deep expertise in postpartum depression (PPD) to discuss the continued clinical unmet needs in PPD and the emerging clinical profile of LPCN 1154 (BRLIZIO™), <span http://www.streetinsider.com/Press+Releases/Lipocine+Inc.+to+Host+Virtual+KOL+Event+Highlighting+Unmet+Needs+in+Postpartum+Depression+and+the+Clinical+Profile+of+LPCN+1154/26602692.html Thu, 04 Jun 2026 08:00:00 -0400 A.06188431 A.10277118 A.16003235 A.19655944 A.23500096 A.30746152 A.32845002 LPCN O.00052323 O.00173928 O.00805111 O.02863032 O.03307993 O.13604276 O.50936666 O.50982008 http://www.streetinsider.com/Press+Releases/Lipocine+Inc.+to+Host+Virtual+KOL+Event+Highlighting+Unmet+Needs+in+Postpartum+Depression+and+the+Clinical+Profile+of+LPCN+1154/26602692.html <div class="xn-content"> <p class="prntac">Live webinar to take place on <chron>Friday, June 12, 2026</chron> at <chron>11:00 AM Eastern Time</chron></p><p><span class="legendSpanClass"><location value="LU/us.ut.sltlkc" idsrc="xmltag.org" >SALT LAKE CITY</location></span>, <span class="legendSpanClass"><chron>June 4, 2026</chron></span> /PRNewswire/ -- Lipocine Inc. (Nasdaq: LPCN), a specialty pharmaceutical company focused on the development of novel oral therapeutics, today announced that it will host a virtual Key Opinion Leader (KOL) event on <b><chron>Friday, June 12, 2026</chron> at <chron>11:00 AM Eastern Time</chron></b>. The event will bring together leading physicians with deep expertise in postpartum depression (PPD) to discuss the continued clinical unmet needs in PPD and the emerging clinical profile of LPCN 1154 (BRLIZIO™), <span http://www.streetinsider.com/Press+Releases/Lipocine+Inc.+to+Host+Virtual+KOL+Event+Highlighting+Unmet+Needs+in+Postpartum+Depression+and+the+Clinical+Profile+of+LPCN+1154/26602692.html Thu, 04 Jun 2026 08:00:00 -0400 A.06188431 A.10277118 A.16003235 A.19655944 A.23500096 A.30746152 A.32845002 LPCN O.00052323 O.00173928 O.00805111 O.02863032 O.03307993 O.13604276 O.50936666 O.50982008 http://www.streetinsider.com/Press+Releases/Lipocine+Inc.+to+Host+Virtual+KOL+Event+Highlighting+Unmet+Needs+in+Postpartum+Depression+and+the+Clinical+Profile+of+LPCN+1154/26602692.html <div class="xn-content"> <p class="prntac">Live webinar to take place on <chron>Friday, June 12, 2026</chron> at <chron>11:00 AM Eastern Time</chron></p><p><span class="legendSpanClass"><location value="LU/us.ut.sltlkc" idsrc="xmltag.org" >SALT LAKE CITY</location></span>, <span class="legendSpanClass"><chron>June 4, 2026</chron></span> /PRNewswire/ -- Lipocine Inc. (Nasdaq: LPCN), a specialty pharmaceutical company focused on the development of novel oral therapeutics, today announced that it will host a virtual Key Opinion Leader (KOL) event on <b><chron>Friday, June 12, 2026</chron> at <chron>11:00 AM Eastern Time</chron></b>. The event will bring together leading physicians with deep expertise in postpartum depression (PPD) to discuss the continued clinical unmet needs in PPD and the emerging clinical profile of LPCN 1154 (BRLIZIO™), <span http://www.streetinsider.com/Press+Releases/Lipocine+Inc.+to+Host+Virtual+KOL+Event+Highlighting+Unmet+Needs+in+Postpartum+Depression+and+the+Clinical+Profile+of+LPCN+1154/26602692.html Thu, 04 Jun 2026 08:00:00 -0400 A.06188431 A.10277118 A.16003235 A.19655944 A.23500096 A.30746152 A.32845002 LPCN O.00052323 O.00173928 O.00805111 O.02863032 O.03307993 O.13604276 O.50936666 O.50982008 http://www.streetinsider.com/Press+Releases/Lipocine+Inc.+to+Host+Virtual+KOL+Event+Highlighting+Unmet+Needs+in+Postpartum+Depression+and+the+Clinical+Profile+of+LPCN+1154/26602692.html <div class="xn-content"> <p class="prntac">Live webinar to take place on <chron>Friday, June 12, 2026</chron> at <chron>11:00 AM Eastern Time</chron></p><p><span class="legendSpanClass"><location value="LU/us.ut.sltlkc" idsrc="xmltag.org" >SALT LAKE CITY</location></span>, <span class="legendSpanClass"><chron>June 4, 2026</chron></span> /PRNewswire/ -- Lipocine Inc. (Nasdaq: LPCN), a specialty pharmaceutical company focused on the development of novel oral therapeutics, today announced that it will host a virtual Key Opinion Leader (KOL) event on <b><chron>Friday, June 12, 2026</chron> at <chron>11:00 AM Eastern Time</chron></b>. The event will bring together leading physicians with deep expertise in postpartum depression (PPD) to discuss the continued clinical unmet needs in PPD and the emerging clinical profile of LPCN 1154 (BRLIZIO™), <span http://www.streetinsider.com/Press+Releases/Lipocine+Inc.+to+Host+Virtual+KOL+Event+Highlighting+Unmet+Needs+in+Postpartum+Depression+and+the+Clinical+Profile+of+LPCN+1154/26602692.html Thu, 04 Jun 2026 08:00:00 -0400 A.06188431 A.10277118 A.16003235 A.19655944 A.23500096 A.30746152 A.32845002 LPCN O.00052323 O.00173928 O.00805111 O.02863032 O.03307993 O.13604276 O.50936666 O.50982008 http://www.streetinsider.com/Press+Releases/Lipocine+Inc.+to+Host+Virtual+KOL+Event+Highlighting+Unmet+Needs+in+Postpartum+Depression+and+the+Clinical+Profile+of+LPCN+1154/26602692.html <div class="xn-content"> <p class="prntac">Live webinar to take place on <chron>Friday, June 12, 2026</chron> at <chron>11:00 AM Eastern Time</chron></p><p><span class="legendSpanClass"><location value="LU/us.ut.sltlkc" idsrc="xmltag.org" >SALT LAKE CITY</location></span>, <span class="legendSpanClass"><chron>June 4, 2026</chron></span> /PRNewswire/ -- Lipocine Inc. (Nasdaq: LPCN), a specialty pharmaceutical company focused on the development of novel oral therapeutics, today announced that it will host a virtual Key Opinion Leader (KOL) event on <b><chron>Friday, June 12, 2026</chron> at <chron>11:00 AM Eastern Time</chron></b>. The event will bring together leading physicians with deep expertise in postpartum depression (PPD) to discuss the continued clinical unmet needs in PPD and the emerging clinical profile of LPCN 1154 (BRLIZIO™), <span http://www.streetinsider.com/Press+Releases/Lipocine+Inc.+to+Host+Virtual+KOL+Event+Highlighting+Unmet+Needs+in+Postpartum+Depression+and+the+Clinical+Profile+of+LPCN+1154/26602692.html Thu, 04 Jun 2026 08:00:00 -0400 A.06188431 A.10277118 A.16003235 A.19655944 A.23500096 A.30746152 A.32845002 LPCN O.00052323 O.00173928 O.00805111 O.02863032 O.03307993 O.13604276 O.50936666 O.50982008 http://www.streetinsider.com/Press+Releases/Lipocine+Inc.+to+Host+Virtual+KOL+Event+Highlighting+Unmet+Needs+in+Postpartum+Depression+and+the+Clinical+Profile+of+LPCN+1154/26602692.html <div class="xn-content"> <p class="prntac">Live webinar to take place on <chron>Friday, June 12, 2026</chron> at <chron>11:00 AM Eastern Time</chron></p><p><span class="legendSpanClass"><location value="LU/us.ut.sltlkc" idsrc="xmltag.org" >SALT LAKE CITY</location></span>, <span class="legendSpanClass"><chron>June 4, 2026</chron></span> /PRNewswire/ -- Lipocine Inc. (Nasdaq: LPCN), a specialty pharmaceutical company focused on the development of novel oral therapeutics, today announced that it will host a virtual Key Opinion Leader (KOL) event on <b><chron>Friday, June 12, 2026</chron> at <chron>11:00 AM Eastern Time</chron></b>. The event will bring together leading physicians with deep expertise in postpartum depression (PPD) to discuss the continued clinical unmet needs in PPD and the emerging clinical profile of LPCN 1154 (BRLIZIO™), <span http://www.streetinsider.com/Press+Releases/Lipocine+Inc.+to+Host+Virtual+KOL+Event+Highlighting+Unmet+Needs+in+Postpartum+Depression+and+the+Clinical+Profile+of+LPCN+1154/26602692.html Thu, 04 Jun 2026 08:00:00 -0400 A.06188431 A.10277118 A.16003235 A.19655944 A.23500096 A.30746152 A.32845002 LPCN O.00052323 O.00173928 O.00805111 O.02863032 O.03307993 O.13604276 O.50936666 O.50982008